Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency: Increased accuracy employing DNA, enzyme, and metabolite analyses

B. M. Hogema, S. Akaboshi, M. Taylor, G. S. Salomons, C. Jakobs, Ruud B. Schutgens, B. Wilcken, S. Worthington, G. Maropoulos, Markus Grompe, K. M. Gibson

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Inherited succinic semialdehyde dehydrogenase (SSADH; EC1.2.1.24; McKusick 271980) deficiency is a defect of GABA degradation which leads to accumulation of 4-hydroxybutyric acid (γ-hydroxybutyric acid; GHB) in physiologic fluids of patients. Prenatal diagnosis (PND) was performed in three at-risk pregnancies employing combinations of: (1) reverse-transcription-polymerase chain reaction (RT-PCR) and genomic DNA amplification followed by sequencing using isolated leukocytes or cultured human lymphoblasts; (2) GHB quantitation in amniotic fluid; or (3) SSADH enzyme assay in chorionic villus (CV) and/or amniocytes. In two pregnancies, all analyses were concordant for prediction of disease status in the fetus. In the third case, enzyme activity in CV (deficient) and metabolite analysis in amniotic fluid (normal) were discordant. For clarification, mutation analysis was undertaken in CV, confirming heterozygosity for the mutation previously identified in the proband. We hypothesize that delayed transit time for shipment of CV between Greece and the United States (8 days) led to enhanced degradation of heterozygous SSADH enzyme activity. Our data demonstrate the importance of combined metabolite, enzyme, and DNA analysis for increased accuracy in the PND of SSADH deficiency.

Original languageEnglish (US)
Pages (from-to)218-222
Number of pages5
JournalMolecular Genetics and Metabolism
Volume72
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Succinate-Semialdehyde Dehydrogenase
Chorionic Villi
Metabolites
Prenatal Diagnosis
Enzyme activity
Fluids
DNA
Enzymes
Amniotic Fluid
Hydroxybutyrates
Degradation
Polymerase chain reaction
Transcription
Pregnancy
gamma-Aminobutyric Acid
Mutation
Amplification
Assays
Greece
Enzyme Assays

Keywords

  • γ-hydroxybutyric acid (GHB)
  • 4-hydroxybutyric aciduria
  • Amniocentesis
  • Amniocytes
  • Autosomal recessive inheritance
  • Chorionic villi
  • GABA (4-aminobutyric acid)
  • Prenatal diagnosis
  • Succinic semialdehyde dehydrogenase

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Endocrinology, Diabetes and Metabolism

Cite this

Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency : Increased accuracy employing DNA, enzyme, and metabolite analyses. / Hogema, B. M.; Akaboshi, S.; Taylor, M.; Salomons, G. S.; Jakobs, C.; Schutgens, Ruud B.; Wilcken, B.; Worthington, S.; Maropoulos, G.; Grompe, Markus; Gibson, K. M.

In: Molecular Genetics and Metabolism, Vol. 72, No. 3, 2001, p. 218-222.

Research output: Contribution to journalArticle

Hogema, BM, Akaboshi, S, Taylor, M, Salomons, GS, Jakobs, C, Schutgens, RB, Wilcken, B, Worthington, S, Maropoulos, G, Grompe, M & Gibson, KM 2001, 'Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency: Increased accuracy employing DNA, enzyme, and metabolite analyses', Molecular Genetics and Metabolism, vol. 72, no. 3, pp. 218-222. https://doi.org/10.1006/mgme.2000.3145
Hogema, B. M. ; Akaboshi, S. ; Taylor, M. ; Salomons, G. S. ; Jakobs, C. ; Schutgens, Ruud B. ; Wilcken, B. ; Worthington, S. ; Maropoulos, G. ; Grompe, Markus ; Gibson, K. M. / Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency : Increased accuracy employing DNA, enzyme, and metabolite analyses. In: Molecular Genetics and Metabolism. 2001 ; Vol. 72, No. 3. pp. 218-222.
@article{af0e33b5fd794a47a18efc0076b9fb6d,
title = "Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency: Increased accuracy employing DNA, enzyme, and metabolite analyses",
abstract = "Inherited succinic semialdehyde dehydrogenase (SSADH; EC1.2.1.24; McKusick 271980) deficiency is a defect of GABA degradation which leads to accumulation of 4-hydroxybutyric acid (γ-hydroxybutyric acid; GHB) in physiologic fluids of patients. Prenatal diagnosis (PND) was performed in three at-risk pregnancies employing combinations of: (1) reverse-transcription-polymerase chain reaction (RT-PCR) and genomic DNA amplification followed by sequencing using isolated leukocytes or cultured human lymphoblasts; (2) GHB quantitation in amniotic fluid; or (3) SSADH enzyme assay in chorionic villus (CV) and/or amniocytes. In two pregnancies, all analyses were concordant for prediction of disease status in the fetus. In the third case, enzyme activity in CV (deficient) and metabolite analysis in amniotic fluid (normal) were discordant. For clarification, mutation analysis was undertaken in CV, confirming heterozygosity for the mutation previously identified in the proband. We hypothesize that delayed transit time for shipment of CV between Greece and the United States (8 days) led to enhanced degradation of heterozygous SSADH enzyme activity. Our data demonstrate the importance of combined metabolite, enzyme, and DNA analysis for increased accuracy in the PND of SSADH deficiency.",
keywords = "γ-hydroxybutyric acid (GHB), 4-hydroxybutyric aciduria, Amniocentesis, Amniocytes, Autosomal recessive inheritance, Chorionic villi, GABA (4-aminobutyric acid), Prenatal diagnosis, Succinic semialdehyde dehydrogenase",
author = "Hogema, {B. M.} and S. Akaboshi and M. Taylor and Salomons, {G. S.} and C. Jakobs and Schutgens, {Ruud B.} and B. Wilcken and S. Worthington and G. Maropoulos and Markus Grompe and Gibson, {K. M.}",
year = "2001",
doi = "10.1006/mgme.2000.3145",
language = "English (US)",
volume = "72",
pages = "218--222",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Prenatal diagnosis of succinic semialdehyde dehydrogenase deficiency

T2 - Increased accuracy employing DNA, enzyme, and metabolite analyses

AU - Hogema, B. M.

AU - Akaboshi, S.

AU - Taylor, M.

AU - Salomons, G. S.

AU - Jakobs, C.

AU - Schutgens, Ruud B.

AU - Wilcken, B.

AU - Worthington, S.

AU - Maropoulos, G.

AU - Grompe, Markus

AU - Gibson, K. M.

PY - 2001

Y1 - 2001

N2 - Inherited succinic semialdehyde dehydrogenase (SSADH; EC1.2.1.24; McKusick 271980) deficiency is a defect of GABA degradation which leads to accumulation of 4-hydroxybutyric acid (γ-hydroxybutyric acid; GHB) in physiologic fluids of patients. Prenatal diagnosis (PND) was performed in three at-risk pregnancies employing combinations of: (1) reverse-transcription-polymerase chain reaction (RT-PCR) and genomic DNA amplification followed by sequencing using isolated leukocytes or cultured human lymphoblasts; (2) GHB quantitation in amniotic fluid; or (3) SSADH enzyme assay in chorionic villus (CV) and/or amniocytes. In two pregnancies, all analyses were concordant for prediction of disease status in the fetus. In the third case, enzyme activity in CV (deficient) and metabolite analysis in amniotic fluid (normal) were discordant. For clarification, mutation analysis was undertaken in CV, confirming heterozygosity for the mutation previously identified in the proband. We hypothesize that delayed transit time for shipment of CV between Greece and the United States (8 days) led to enhanced degradation of heterozygous SSADH enzyme activity. Our data demonstrate the importance of combined metabolite, enzyme, and DNA analysis for increased accuracy in the PND of SSADH deficiency.

AB - Inherited succinic semialdehyde dehydrogenase (SSADH; EC1.2.1.24; McKusick 271980) deficiency is a defect of GABA degradation which leads to accumulation of 4-hydroxybutyric acid (γ-hydroxybutyric acid; GHB) in physiologic fluids of patients. Prenatal diagnosis (PND) was performed in three at-risk pregnancies employing combinations of: (1) reverse-transcription-polymerase chain reaction (RT-PCR) and genomic DNA amplification followed by sequencing using isolated leukocytes or cultured human lymphoblasts; (2) GHB quantitation in amniotic fluid; or (3) SSADH enzyme assay in chorionic villus (CV) and/or amniocytes. In two pregnancies, all analyses were concordant for prediction of disease status in the fetus. In the third case, enzyme activity in CV (deficient) and metabolite analysis in amniotic fluid (normal) were discordant. For clarification, mutation analysis was undertaken in CV, confirming heterozygosity for the mutation previously identified in the proband. We hypothesize that delayed transit time for shipment of CV between Greece and the United States (8 days) led to enhanced degradation of heterozygous SSADH enzyme activity. Our data demonstrate the importance of combined metabolite, enzyme, and DNA analysis for increased accuracy in the PND of SSADH deficiency.

KW - γ-hydroxybutyric acid (GHB)

KW - 4-hydroxybutyric aciduria

KW - Amniocentesis

KW - Amniocytes

KW - Autosomal recessive inheritance

KW - Chorionic villi

KW - GABA (4-aminobutyric acid)

KW - Prenatal diagnosis

KW - Succinic semialdehyde dehydrogenase

UR - http://www.scopus.com/inward/record.url?scp=18244371105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18244371105&partnerID=8YFLogxK

U2 - 10.1006/mgme.2000.3145

DO - 10.1006/mgme.2000.3145

M3 - Article

C2 - 11243727

AN - SCOPUS:18244371105

VL - 72

SP - 218

EP - 222

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 3

ER -